Literature DB >> 2069709

Analytical studies on tobacco-specific N-nitrosamines in tobacco and tobacco smoke.

K D Brunnemann1, D Hoffmann.   

Abstract

Chemical-analytical studies have led to the identification of approximately 3000 compounds in tobacco and 4000 in tobacco smoke. These include carcinogens in processed tobacco as well as tumor initiators, tumor promoters, cocarcinogens, and organ-specific carcinogens in tobacco smoke. The latter group includes N-nitrosamines, in particular those that derive from nicotine and other tobacco alkaloids, the TSNA. In vitro nitrosation of nicotine yields NNN, NNA, and NNK. Nitrosation of other tobacco alkaloids leads to the formation of NAT, and NAB. Our analytical studies using GC-TEA have led to the identification of seven TSNA in tobacco and tobacco smoke. In addition to NNN, NAT, NAB, and NNK, we also identified NNAL, iso-NNAL, and, most recently, iso-NNAC. Their levels range from 0.01 to 92 ppm in tobacco and from 6 to 530 ng/cigarette in tobacco smoke. The high levels observed in snuff are primarily due to fermentation and aging. Technological methods exist today to reduce the levels of TSNA in both tobacco and cigarette smoke.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2069709     DOI: 10.3109/10408449109017910

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  30 in total

1.  Substance use during pregnancy: time for policy to catch up with research.

Authors:  Barry M Lester; Lynne Andreozzi; Lindsey Appiah
Journal:  Harm Reduct J       Date:  2004-04-20

2.  Microbial community structure and dynamics of dark fire-cured tobacco fermentation.

Authors:  Michele Di Giacomo; Marianna Paolino; Daniele Silvestro; Giovanni Vigliotta; Francesco Imperi; Paolo Visca; Pietro Alifano; Dino Parente
Journal:  Appl Environ Microbiol       Date:  2006-12-01       Impact factor: 4.792

3.  Levels of toxins in oral tobacco products in the UK.

Authors:  A McNeill; R Bedi; S Islam; M N Alkhatib; R West
Journal:  Tob Control       Date:  2006-02       Impact factor: 7.552

4.  Passive smoking, cytochrome P450 gene polymorphisms and dysmenorrhea.

Authors:  Lou Lei; Linan Ye; Hong Liu; Changzhong Chen; Zhian Fang; Lihua Wang; Yonghua Hu; Dafang Chen
Journal:  Eur J Epidemiol       Date:  2008-04-25       Impact factor: 8.082

5.  Maternal tobacco use modestly alters correlated epigenome-wide placental DNA methylation and gene expression.

Authors:  Melissa Suter; Jun Ma; Alan Harris; Lauren Patterson; Kathleen A Brown; Cynthia Shope; Lori Showalter; Adi Abramovici; Kjersti M Aagaard-Tillery
Journal:  Epigenetics       Date:  2011-11-01       Impact factor: 4.528

Review 6.  Maternal smoking as a model for environmental epigenetic changes affecting birthweight and fetal programming.

Authors:  Melissa A Suter; Amber M Anders; Kjersti M Aagaard
Journal:  Mol Hum Reprod       Date:  2012-11-08       Impact factor: 4.025

7.  Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains.

Authors:  A Khanna; M Guo; M Mehra; W Royal
Journal:  J Neuroimmunol       Date:  2012-09-30       Impact factor: 3.478

Review 8.  Maternal smoking during pregnancy and child outcomes: real or spurious effect?

Authors:  Valerie S Knopik
Journal:  Dev Neuropsychol       Date:  2009       Impact factor: 2.253

9.  Nicotine promotes tumor growth and metastasis in mouse models of lung cancer.

Authors:  Rebecca Davis; Wasia Rizwani; Sarmistha Banerjee; Michelle Kovacs; Eric Haura; Domenico Coppola; Srikumar Chellappan
Journal:  PLoS One       Date:  2009-10-20       Impact factor: 3.240

10.  Effects of maternal tobacco-smoke exposure on fetal growth and neonatal size.

Authors:  Shane Reeves; Ira Bernstein
Journal:  Expert Rev Obstet Gynecol       Date:  2008-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.